Quadlytics Inc.
PrivateLast Round
Series B
Nov 3, 2026
Total Funding Raised
$10.02M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Quadlytics Inc. operates in Healthcare & Life Sciences and is based in Kyoto. Its latest recorded funding round was a Series B round in November 2026.
Quadlytics Inc. is a medical technology company that develops a wearable epileptic seizure prediction system using real-time autonomic nervous system analytics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quadlytics Inc. Comparables
Compare Quadlytics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroHelp | 86% | |
| MJN Neuroservis | 83% | |
| Epilert | 78% |
For institutional investors. Book with your work email.
Quadlytics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 3, 2026 | ||||
| Series A | May 30, 2025 | ||||
| Grant | Sep 11, 2024 | ||||
| Seed | Dec 26, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Quadlytics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lifetime Ventures | Series B, Series A |
| The Actuator | Series A, Accelerator |
| XTech Ventures | Series B, Series A |
| Kyoto Capital Partners | Series A |
| かんぽNEXTパートナーズ株式会社 | Series B |
| Samurai Incubate Inc. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2026
$4M round with participation from XTech Ventures and Lifetime Ventures.
- Aug 21, 2026
Monthly visitors increased 513% MoM, from 40 to 245.
For institutional investors. Book with your work email.
Quadlytics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Quadlytics Inc.'s valuation, stock price, and market status.
Is Quadlytics Inc. a public or private company?
Quadlytics Inc. is a private company.
What is the current stock price of Quadlytics Inc.?
Quadlytics Inc. is a private company, so its shares have no public market price. Caplight tracks Quadlytics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Quadlytics Inc. worth (valuation)?
Valuation information for Quadlytics Inc. is not publicly available.
Can I buy Quadlytics Inc. stock?
Quadlytics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Quadlytics Inc.'s last funding round?
Quadlytics Inc.'s most recent funding round was Series B on November 3, 2026.
Who are the main investors in Quadlytics Inc.?
Key investors in Quadlytics Inc. include Lifetime Ventures.
Will Quadlytics Inc. IPO soon?
No public IPO plans have been announced for Quadlytics Inc..
How can I track Quadlytics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Quadlytics Inc.'s shares on secondary markets.